References
- van Hemert A M, Birkenhager J C, de Jong F H, Vandenbroucke J P, Valkenburg H A. Sex hormone binding globulin in postmenopausal women: A predictor of osteoporosis superior to endogenous oestrogens. Clin Endocrinol 1989; 31: 499–509
- Ralston S H. Scand J Clin Lab Invest 1997; 57: 114–121, (Suppl 227)
- Consensus Development Conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 1991; 90: 107–110
- World Health Organisation. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO, Geneve 1994, WHO Technical Report Series 843
- Kanis J A, Melton L J, Christiansen C, Johnston C C, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137–1141
- Garnero P, Sornay-Rendu E, Chapuy M C, Delmas P D. Increased bone turnover is a major determinant of osteoporosis in elderly women. J Bone Miner Res 1996; 3: 337–349
- Kanis J A, McCloskey E V, Eyres K S, O'Doherty D V, Aaron J E. Screening techniques in the evaluation of osteoporosis. HRT and osteoporosis, J O Drife, J WW Studd. Springer Verlag, London 1990; 135–147, Chapter 12
- Christiansen C, Riis B J, Nilas L, Rodbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis. Lancet 1985; 2: 800–801
- Morris H A, Wishart J M, Horowitz M, Need A G, Nordin B EC. The reproducibility of bone-related biochemical variables in postmenopausal women. Ann Clin Biochem 1990; 27: 562–568
- Vasikaran S D, McCloskey E V, Khan S, Kanis J A. Intra-individual variation in fasting urinary calcium- and hydroxyproline-creatinine ratios measured in metabolic bone clinic patients as both outpatients and inpatients. Ann Clin Biochem 1994; 31: 1–5
- Riis B J. The role of bone loss. Am J Med 1995; 98: 29–32, (suppl 2A)
- Christiansen C, Riis B J, Rodbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105–1108
- Hansen M, Overgaard K, Riis B, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. Br Med J 1991; 303: 961–964
- Johansen J S, Riis B J, Delmas P D, Christiansen C. Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 1988; 18: 191–195
- Christiansen C. What should be done at the time of menopause?. Am J Med 1995; 98: 56–59, (suppl 2A)
- Uebelhart D, Schlemmer A, Johansen J S, Gineyts Christiansen C, Delmas P D. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 1991; 72: 367–373
- Kanis J A, Adami S. Bone loss in the elderly. Osteoporosis Int 1994; 4: 59–65, (suppl 1)
- Garnero P, Hansherr E, Chapuy M C, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier P J, Delmas P D. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS study. J Bone Miner Res 1997, in press
- Kanis J A, McCloskey E V. Evaluation of the risk of hip fracture. Bone 1996; 18: 127s–132s
- Wishart J M, Need A G, Horowitz M, Morris H A, Nordin B EC. Effect of age on bone density and bone turnover in men. Clin Endocrinol 1995; 42: 141–146
- Chesnut C H, McClung M R, Ensrud K E, Bell N H, Genant H K, Harris S T, Singer F R, Stock J L, Yood R L, Delmas P D, Kher U, Pryor-Tillotson S, Santora A C. Alendronate treatment of the postmenopausal osteoporotic women: effect of multiple dosages on bone mass and bone remodeling. Am J Med 1995; 99: 142–152
- Garnero P, Shih W J, Gineyts E, Karpf D B, Delmas P D. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994; 79: 1693–1700
- Munk N Nielsen, von der Recke P, Hansen M A, Overgaard K, Christiansen C. Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers. Calcif Tissue Int 1994; 55: 8–11